Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.16 | 43.48 |
PEG Ratio (TTM) | -0.02 | 1.96 |
P/S Ratio (TTM) | 1.10 | 2.30 |
P/B Ratio (TTM) | 0.59 | 2.63 |
P/FCF Ratio (TTM) | -0.15 | 14.87 |
Price to 5YR AVG Earnings Ratio | N/A | 1.81 |
Price to 5YR AVG FCF Ratio | N/A | 56.73 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -3.61% | 6.39% |
ROE (TTM) | -43.14% | 11.24% |
Net Profit Margin (TTM) | -41.20% | 7.39% |
ROIC 5YR AVG | N/A | 5.25% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | N/A | -1,698.69% | N/A |
Revenue | N/A | 252.29% | N/A |
Net Income | N/A | -1,641.85% | N/A |
Cash Flow | N/A | 490.36% | N/A |
Health (12%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.28 | 2.65 |
Quick Ratio (TTM) | 0.28 | 2.59 |
D/E Ratio (TTM) | 4.01 | 0.26 |
Interest Coverage (TTM) | 0.13 | 20.72 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | N/A | 4.41 |
LTL to 5YR AVG FCF | N/A | 5.83 |
Shares Outstanding Growth 5YR AVG | N/A | 90.71% |